Trial intelligence / Profile preview

PECULIAR: Pemetrexed + Cisplatin in Advanced Urothelial Cancer

NCT01490437Phase 2Completed

Sponsor
Asan Medical Center
Start
Jul 2008
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pemetrexed in urothelial carcinoma (UC), sponsored by Asan Medical Center. Started Jul 2008; status: completed.

02

Drugs

pemetrexed
03

Conditions

urothelial carcinoma (UC)

Beyond the preview

Go deeper on NCT01490437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01490437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call